HITI:NSD-High Tide Inc (USD)

COMMON STOCK | Pharmaceutical Retailers |

Last Closing

USD 2.14

Change

-0.01 (-0.47)%

Market Cap

USD 0.18B

Volume

0.53M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-23 )

Largest Industry Peers for Pharmaceutical Retailers

Symbol Name Price(Change) Market Cap
WBA Walgreens Boots Alliance Inc

-0.16 (-0.87%)

USD 14.83B
PETS PetMed Express Inc

-0.02 (-0.33%)

USD 0.10B
BIMI Bimi International Medical Inc

+0.11 (+9.57%)

USD 0.01B
MEDS Trxade Group Inc

+0.22 (+3.91%)

USD 8.10M
CJJD China Jo-Jo Drugstores Inc

+0.44 (+17.21%)

USD 5.41M
LFLY Leafly Holdings Inc

-0.09 (-4.50%)

USD 4.37M
LFLYW Leafly Holdings Inc

-0.01 (-28.87%)

N/A
MDVLQ MedAvail Holdings Inc

N/A

N/A

ETFs Containing HITI

BUDX 5.19 % 0.00 %

N/A

N/A
MJ Amplify Alternative Harve.. 1.92 % 0.75 %

-0.11 (0%)

USD 0.25B
YOLO AdvisorShares Pure Cannab.. 0.00 % 0.00 %

-0.15 (0%)

USD 0.05B

Market Performance

  Market Performance vs. Industry/Classification (Pharmaceutical Retailers) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 31.29% 88% B+ 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 31.29% 88% B+ 87% B+
Trailing 12 Months  
Capital Gain 69.84% 100% F 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 69.84% 100% F 90% A-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -22.21% 78% C+ 17% F
Dividend Return -22.21% 78% C+ 16% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 39.91% 89% A- 45% F
Risk Adjusted Return -55.66% 44% F 19% F
Market Capitalization 0.18B 88% B+ 46% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.